AIDS WEEKLY Plus - December 2004Important note: Information in this article was accurate in December 2004. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

DonateNow
Print this Article

HIV/AIDS Research: Viremic HIV-1 infection associated with increased overall NK cell activity

AIDSWEEKLY Plus; Monday, December 20, 2004
Staff Medical Writers


NewsRx -- Viremic HIV-1 infection is associated with increased overall natural killer (NK) cell activity.

According to recent research from the United States, "NK cells are a subset of granular lymphocytes that are critical in the innate immune response to infection. These cells are capable of killing infected cells and secreting integral cytokines and chemokines.

"The role that this subset of cytolytic cells plays in HIV infection is not well understood. In this study, we dissected the function of NK cells in viremic and aviremic HIV-1-infected subjects, as well as HIV-1-negative control individuals."

"Despite reduced NK cell numbers in subjects with ongoing viral replication," reported G. Alter and colleagues, "these cells were significantly more active in secreting both IFN-γ and TNF-α than NK cells from aviremic subjects or HIV-1-negative controls.

"In addition, NK cells in subjects with detectable viral loads expressed significantly higher levels of CD107a, a marker of lysosomal granule exocytosis."

"The expression of CD107a correlated with NK cell-mediated cytokine secretion and cytolytic activity as well as with the level of viral replication," continued scientists, "suggesting that CD107a represents a good marker for the functional activity of NK cells."

"Finally," Alter continued, "killer Ig-related receptor+ NK cells were stable or elevated in viremic subjects, while the numbers of CD3-/CD56+/CD94+ and CD3-/CD56+/CD161+ NK cells were reduced."

"Taken together, these data demonstrate that viremic HIV-1 infection is associated with a reduction in NK cell numbers and a perturbation of NK cell subsets, but increased overall NK cell activity," the authors concluded.

Alter and colleagues published their study in the Journal of Immunology (Increased natural killer cell activity in viremic HIV-1 infection. J Immunol. 2004 Oct 15;173(8):5305-11.

For additional information, contact M. Altfeld, Massachusetts General Hospital, Partners AIDS Research Center, Boston, MA 02129, USA.

Publisher contact information for the Journal of Immunology is: American Association Immunologists, 9650 Rockville Pike, Bethesda, MD 20814, USA.

The information in this article comes under the major subject areas of HIV/AIDS, Natural Killer Cells, Cytokines, Viremia, and Immunology.

This article was prepared by AIDS Weekly editors from staff and other reports.

Reference

Alter G, Malenfant JM, Delabre RM, et al., "Increased natural killer cell activity in viremic HIV-1 infection", J Immunol. 2004 Oct 15;173(8):5305-11.

PubMED Related articles Search

041220
AW041209


Copyright © 2004 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright © 1980,2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.